Search
Johnson & Johnson
JNJAdd to Watchlist
259.360USD
+3.730+1.46%
Close 07-23 16:00（ET）Quotes delayed by 15 min
624.17BMarket Cap
29.68P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-23The current earnings forecast score of Johnson & Johnson is 7.78, ranking 95 out of 155 in the Pharmaceuticals industry. The average price target is 205.00, with a high of 230.00 and a low of 170.00.
Analyst Rating
Based on
27
analysts
Buy
Current Rating
266.384
Target Price
+6.29%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Johnson & Johnson
JNJ
27
Biogen Inc
BIIB
38
Amgen Inc
AMGN
37
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
33
Pfizer Inc
PFE
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Johnson & Johnson's expected revenue for the next quarter?
Johnson & Johnson's expected revenue is 25.32B.
What is Johnson & Johnson's price target?
Analysts forecast that Johnson & Johnson's price target is USD 205.00, with the highest forecast at USD 230.00 and the lowest forecast at USD 170.00.
How have Johnson & JohnsonJNJ's recent earnings per share performed?
The market expectation was USD 2.27, while Johnson & JohnsonJNJ's earnings per share (EPS) for the previous quarter was USD 2.17. EPS for the next quarter is expected at USD 3.05.
What is the analyst rating for Johnson & Johnson?
Based on the ratings of Johnson & Johnson's stock from 27 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.